Moleculin BiotechMBRX
13F holders, Q4 2024 (December 31)21holders +2
3new positions
2sold out
1famous investor
$1.70avg. 13F price*
At the end of Q4 2024, 21 institutions reported holding Moleculin Biotech Inc. (MBRX) in their 13F filings, up 2 from Q3 2024. 3 opened new positions and 2 sold out. The largest holders were Armistice Capital, LLC ($540K), LPL Financial LLC ($70K) and Vanguard Group Inc. ($53K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Moleculin Biotech Inc.
- CUSIP
- 60855D309
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $16K |
| Exits | 2 | $9 |
All 13F filers, Q3 2024 → Q4 2024: 44,907 shares bought and 41,178 shares sold, net +3,729 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 21 holders
| Armistice Capital, LLC | 0.01% | Add +9.5% | 317,586 | $540K |
| LPL Financial LLC | 0.00% | Add +14.2% | 41,215 | $70K |
| Vanguard Group Inc. | 0.00% | Reduce -56.7% | 30,935 | $53K |
| Geode Capital Management, LLC | 0.00% | Add +0.9% | 22,024 | $37K |
| BlackRock, Inc. | 0.00% | Reduce -0.8% | 12,380 | $21K |
| Renaissance Technologies | 0.00% | Add +4.5% | 11,496 | $20K |
| Truist Financial Corp. | 0.00% | No change | 10,500 | $18K |
| UBS Group AG | 0.00% | New | 8,939 | $15K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +122.2% | 4,024 | $7K |
| Atticus Wealth Management, LLC | 0.00% | Reduce -16.5% | 2,784 | $5K |
| NFSG Corp | 0.00% | No change | 1,367 | $2K |
| Morgan Stanley | 0.00% | Reduce -5.1% | 426 | $724 |
| SBI Securities Co., Ltd. | 0.00% | — | 405 | $689 |
| Bogart Wealth, LLC | 0.00% | New | 300 | $510 |
| Bank of America Corp. | 0.00% | Reduce -27.3% | 104 | $176 |
| Sandy Spring Bank | 0.00% | No change | 89 | $152 |
| Osaic Holdings, Inc. | 0.00% | Add +113.0% | 49 | $83 |
| CVA Family Office, LLC | 0.00% | No change | 34 | $58 |
| Kestra Investment Management, LLC | 0.00% | New | 25 | $43 |
| North Star Investment Management Corp. | 0.00% | No change | 17 | $29 |
| Royal Bank of Canada | 0.00% | No change | 1 | $0 |
"% of holder's portfolio" is MBRX's weight in each manager's 13F, not the share of Moleculin Biotech Inc. the manager owns.